Document is current
Any future updates will be listed below
-
Authors
,
Paz-Ares, Luis
- License Information
-
More Information
Article History
First Online: 8 December 2020
Competing interests:
: L.P.-A. has attended advisory boards or received consulting fees for Roche, Lilly, Novartis, AstraZeneca, Pfizer, Amgen, MSD, BMS, Merck Serono, Incyte, Boehringer Ingelheim and Pharmamar. The author does not report any conflict of interest with regards to the contents of this study other than those stated.
: This promotional supplement has been commissioned and funded by AstraZeneca UK Limited (‘AstraZeneca’).
